Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Skin Analytics
Recursion Pharmaceuticals' $239M for AI drug discovery, optimize.health's $15.6M for remote patient monitoring and more digital health fundings
By
Dave Muoio
|
03:14 pm |
September 10, 2020
Also: Skin Analytics' Series A contributes to AI-based detection of potential skin cancer; China's LickDoc supports its healthcare big data repository with $102 million.